Zaidi S I, Raisuddin S, Singh K P, Jafri A, Husain R, Husain M M, Mall S A, Seth P K, Ray P K
Preventive Toxicology Division, Industrial Toxicology Research Centre, Lucknow, India.
Immunopharmacol Immunotoxicol. 1994 May;16(2):247-60. doi: 10.3109/08923979409007093.
In the present communication, we describe acrylamide (ACR) induced immunotoxicity and its modulation by an interferon inducer, the 6th mycelial fraction acetone (6-MFA) of Aspergillus ochraceus ATCC 28706. ACR administration to rats produced a significant decrease in the weight of spleen (p < 0.001), thymus (p < 0.001) and mesenteric lymph nodes (p < 0.05). A decrease in cellularity of spleen (p < 0.001), thymus (p < 0.001), bone marrow (p < 0.001) and circulating blood lymphocyte population (p < 0.001) was also recorded. ACR suppressed the humoral as well as cell mediated immunity as assessed by erythrocyte antibody complement (EAC)-rosettes (p < 0.001), hemagglutination titre (p < 0.001), PFC (p < 0.001) and the delayed type hypersensitivity response against sheep red blood cells (SRBC, p < 0.001). ACR treated immunosuppressed rats when treated with 6-MFA restored the circulating lymphocyte number to the normal level and a partial recovery in the weight of spleen and thymus. Potentiation of EAC-rosettes, hemagglutination titre, IgM-PFC and DTH response against SRBC was observed. It is concluded that 6-MFA ameliorate the ACR induced toxicity. This study may be of significance in prevention of ACR toxicity.
在本通讯中,我们描述了丙烯酰胺(ACR)诱导的免疫毒性以及由赭曲霉ATCC 28706的第六菌丝体级分丙酮(6-MFA)这种干扰素诱导剂对其的调节作用。给大鼠施用ACR导致脾脏重量显著降低(p < 0.001)、胸腺重量显著降低(p < 0.001)以及肠系膜淋巴结重量显著降低(p < 0.05)。还记录到脾脏(p < 0.001)、胸腺(p < 0.001)、骨髓(p < 0.001)和循环血液淋巴细胞群体数量减少(p < 0.001)。通过红细胞抗体补体(EAC)花环试验(p < 0.001)、血凝滴度(p < 0.001)、PFC(p < 0.001)以及针对绵羊红细胞(SRBC)的迟发型超敏反应(p < 0.001)评估发现,ACR抑制了体液免疫以及细胞介导的免疫。用6-MFA处理经ACR处理的免疫抑制大鼠后,循环淋巴细胞数量恢复到正常水平,脾脏和胸腺重量部分恢复。观察到EAC花环试验、血凝滴度、IgM-PFC以及针对SRBC的DTH反应增强。得出的结论是,6-MFA改善了ACR诱导的毒性。本研究对于预防ACR毒性可能具有重要意义。